Clinical Trial

Study of ZG005 in Combination With Gecacitinib and Chemotherapy for Participants With Advanced Solid Tumors

Name: Study of ZG005 in Combination With Gecacitinib and Chemotherapy for Participants With Advanced Solid Tumors — clinical trial record (NCT07142837)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 1/2

View on ClinicalTrials.gov →

Summary

This is a multicenter, open-label phase I/II study for participants with advanced solid tumors who have failed prior immune checkpoint inhibitor therapies.

Trial Details

NCT Number	NCT07142837
Lead Sponsor	Suzhou Zelgen Biopharmaceuticals Co.,Ltd
Conditions	Advanced Solid Tumor
Enrollment	153 participants
Start Date	2025-09
Primary Completion	2027-10 (estimated)
Study Completion	2027-12 (estimated)
Updated on ClinicalTrials.gov	2025-08-27